This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2024 Apr 10;12(4):834.

doi: 10.3390/biomedicines12040834.

Correction: D'Amico et al. Toxic Exposure to Endocrine Disruptors Worsens Parkinson's Disease Progression through NRF2/HO-1 Alteration. Biomedicines 2022, 10, 1073

Affiliations

Affiliations

¹ Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166 Messina, Italy.
² Department of Veterinary Science, University of Messina, 98168 Messina, Italy.
³ Department of Biomedical, Dental and Morphological and Functional Imaging, University of Messina, 98125 Messina, Italy.
⁴ Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.

PMID: 38672284
PMCID: PMC11048085
DOI: 10.3390/biomedicines12040834

Published Erratum

Correction: D'Amico et al. Toxic Exposure to Endocrine Disruptors Worsens Parkinson's Disease Progression through NRF2/HO-1 Alteration. Biomedicines 2022, 10, 1073

Ramona D'Amico et al. Biomedicines. 2024.

. 2024 Apr 10;12(4):834.

doi: 10.3390/biomedicines12040834.

Affiliations

¹ Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166 Messina, Italy.
² Department of Veterinary Science, University of Messina, 98168 Messina, Italy.
³ Department of Biomedical, Dental and Morphological and Functional Imaging, University of Messina, 98125 Messina, Italy.
⁴ Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.

PMID: 38672284
PMCID: PMC11048085
DOI: 10.3390/biomedicines12040834

Abstract

Errors in Figures [...].

PubMed Disclaimer

Figures

Figure 2
Immunohistochemical evaluation in the midbrain for TH expression (A). Graphical quantification of TH expression (B). Western blots and densitometric analysis of TH (C) and DAT (D). A 20× magnification is shown (100-µm scale bar). A demonstrative blot of lysates with a densitometric analysis for all animals is shown. Data are expressed as the mean ± SEM of N = 6 mice/group. * p < 0.05 vs. sham; ** p < 0.01 vs. sham; *** p < 0.001 vs. sham; # p < 0.05 vs. MPTP; ## p < 0.01 vs. MPTP; ### p < 0.001 vs. MPTP.

Figure 3
Immunohistochemical evaluation for α-syn expression (A). Graphical quantification of α-syn expression (B). Western blot and densitometric analysis of α-syn (C). A 40× magnification is shown (75-µm scale bar). A demonstrative blot of lysates with a densitometric analysis for all animals is shown. Data are expressed as the mean ± SEM of N = 6 mice/group. * p < 0.05 vs. sham; ** p < 0.01 vs. sham; *** p < 0.001 vs. sham; # p < 0.05 vs. MPTP; ## p < 0.01 vs. MPTP; ### p < 0.001 vs. MPTP.

See this image and copyright information in PMC

Erratum for

Toxic Exposure to Endocrine Disruptors Worsens Parkinson's Disease Progression through NRF2/HO-1 Alteration.
D'Amico R, Gugliandolo E, Siracusa R, Cordaro M, Genovese T, Peritore AF, Crupi R, Interdonato L, Di Paola D, Cuzzocrea S, Fusco R, Impellizzeri D, Di Paola R. D'Amico R, et al. Biomedicines. 2022 May 5;10(5):1073. doi: 10.3390/biomedicines10051073. Biomedicines. 2022. PMID: 35625810 Free PMC article.

Similar articles

Toxic Exposure to Endocrine Disruptors Worsens Parkinson's Disease Progression through NRF2/HO-1 Alteration.
D'Amico R, Gugliandolo E, Siracusa R, Cordaro M, Genovese T, Peritore AF, Crupi R, Interdonato L, Di Paola D, Cuzzocrea S, Fusco R, Impellizzeri D, Di Paola R. D'Amico R, et al. Biomedicines. 2022 May 5;10(5):1073. doi: 10.3390/biomedicines10051073. Biomedicines. 2022. PMID: 35625810 Free PMC article.
Optimizing D'Amico risk groups in radical prostatectomy through the addition of magnetic resonance imaging data.
Algarra R, Zudaire B, Tienza A, Velis JM, Rincón A, Pascual I, Zudaire J. Algarra R, et al. Actas Urol Esp. 2014 Nov;38(9):594-9. doi: 10.1016/j.acuro.2014.03.003. Epub 2014 May 3. Actas Urol Esp. 2014. PMID: 24791621 English, Spanish.
Altered significance of D'Amico risk classification in patients with prostate cancer linked to a familial breast cancer (kConFab) cohort.
Bolton D, Cheng Y, Willems-Jones AJ, Li J, Niedermeyr E, Mitchell G, Clouston D, Lawrentschuk N, Sliwinski A, Fox S, Thorne H. Bolton D, et al. BJU Int. 2015 Aug;116(2):207-12. doi: 10.1111/bju.12792. Epub 2015 Apr 6. BJU Int. 2015. PMID: 24784491
Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson's Disease.
Wang Y, Gao L, Chen J, Li Q, Huo L, Wang Y, Wang H, Du J. Wang Y, et al. Front Pharmacol. 2021 Nov 23;12:757161. doi: 10.3389/fphar.2021.757161. eCollection 2021. Front Pharmacol. 2021. PMID: 34887759 Free PMC article. Review.
Role of Nrf2 in bisphenol effects: a review study.
Salehabadi A, Farkhondeh T, Harifi-Mood MS, Aschner M, Samarghandian S. Salehabadi A, et al. Environ Sci Pollut Res Int. 2022 Aug;29(37):55457-55472. doi: 10.1007/s11356-022-20996-3. Epub 2022 Jun 9. Environ Sci Pollut Res Int. 2022. PMID: 35680748 Review.

See all similar articles

References

1. D’Amico R., Gugliandolo E., Siracusa R., Cordaro M., Genovese T., Peritore A.F., Crupi R., Interdonato L., Di Paola D., Cuzzocrea S., et al. Toxic Exposure to Endocrine Disruptors Worsens Parkinson’s Disease Progression through NRF2/HO-1 Alteration. Biomedicines. 2022;10:1073. doi: 10.3390/biomedicines10051073. - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources